Research & Development

超碰在线视频色天使色姐妹在线视频久久精品视频在线看4康得新事件揭露A股制度风险 专家建议加大处罚力度


  雲音仰著頭瞅著巨大的彩球道︰“這是什麼?”超碰在线视频   “張安世提出來了一個銀行的念頭,我這些天仔細參研之後覺得還是有些用處的,所以,準備讓張安世,桑弘羊開始籌備!”色天使色姐妹在线视频   雲音仰著頭瞅著巨大的彩球道︰“這是什麼?”   第一名疇這些真正的漢人必須要成為羌人們羨慕的人群,他們也是雲瑯統治涼州的基本人群。久久精品视频在线看4   今日沒有課業,李禹,霍一,霍三都脫得精光,在蓮花池子里的瞎撲騰。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo